Gilead on Thursday disclosed that Trodelvy, the antibody-drug conjugate that is a key part of the drugmaker’s oncology business, failed a Phase 3 study after …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The potential and limitations of artificial intelligence (AI)-based large language models (LLMs) in medical research.
The global prevalence of sleep disturbances in children and adolescents during the COVID-19 pandemic.
EQS-News: Douglas GmbH / Key word(s): Interim Report/9 Month figures Douglas GmbH: Publication of results for the 3rd quarter 2022/23 (ending 30 June 2023) on